Trials / NCT04141891
Advancing Understanding of Transportation Options
Completed N/A Other
- Sponsor
- University of Colorado, Denver
- Treatment
- Driving Decision Aid; Older Drivers Website
- Gene
- Not stated
- Conditions
- Diabetic Retinopathy, Macular Degeneration, Glaucoma, Retinitis Pigmentosa, Vision Disorders, Acute Coronary Syndrome, Implantable Defibrillator User, Congestive Heart Failure, Hypertrophic Obstructive Cardiomyopathy, Orthostatic Hypotension, Syncope, Presyncope, Narcolepsy, Dementia, Multiple Sclerosis, Parkinson Disease, Brain Injuries, Spinal Cord Injuries, Stroke, Vertigo, Dizziness, Seizures, Substance Use, Insulin Dependent Diabetes Mellitus, Arthritis, Foot--Abnormalities, Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea, End Stage Renal Disease, Sleep Apnea, Insomnia, Restless Legs Syndrome
- Ages
- 18 Years to no upper limit
- Enrollment
- 529 participants
- Started
- 2019-12-12
- Main results expected
- 2023-06-23
- Results posted
- Yes
- Record last updated
- 2025-02-21
What the study is testing
This Stage II randomized, controlled, longitudinal trial seeks to assess the acceptability, feasibility, and effects of a driving decision aid use among geriatric patients and providers. This multi-site trial will (1) test the driving decision aid (DDA) in improving decision making and quality (knowledge, decision conflict, values concordance and behavior intent); and (2) determine its effects on specific subpopulations of older drivers (stratified for cognitive function, decisional capacity, and attitudinally readiness for a mobility transition). The overarching hypotheses are that the DDA will help older adults make high-quality decisions, which will mitigate the negative psychosocial impacts of driving reduction, and that optimal DDA use will target certain populations and settings.
Where it runs
United States (3)
- University of California, San Diego, La Jolla, California
- CU Anschutz Medical Center, Aurora, Colorado
- Indiana University, Indianapolis, Indiana